Competition for Clinical Trials in Inflammatory Bowel Diseases
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference6 articles.
1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015
2. Prevalence of inflammatory bowel disease among adults aged ≥18 years—United States, 2015;Dahlhamer;MMWR Morb Mortal Wkly Rep,2016
3. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States;Nguyen;J Crohn’s Colitis,2014
4. Improving protocol design feasibility to drive drug development economics and performance;Getz;Int J Environ Res Public Health,2014
5. Innovative trial designs in GI drug development: why trials succeed and fail—a brief report from 2018 Digestive Disease Week;Harris;Gastroenterology,2019
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Basket, Umbrella, and Platform Trials: The Potential for Master Protocol–Based Trials in Inflammatory Bowel Disease;Gastroenterology;2024-09
2. The Future of Clinical Trials in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07
3. Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials;Journal of Crohn's and Colitis;2024-06-22
4. Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials;Inflammatory Bowel Diseases;2024-06-11
5. Tips and tricks for successfully conducting a multicenter study;Gastroenterología y Hepatología (English Edition);2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3